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Iron is essential for normal cellular homeostasis but in excess promotes free radical formation and
is detrimental. Therefore, iron metabolism is tightly regulated. Here, we show that mechanisms
regulating systemic iron metabolism may also control iron release into the brain at the blood-
choroid plexus-cerebrospinal fluid (CSF) barrier. Intraperitoneal administration of lipopolysaccha-
ride (LPS) in mice triggers a transient transcription of the gene encoding for hepcidin, a key
regulator of iron homeostasis, in the choroid plexus, which correlated with increased detection of
pro-hepcidin in the CSF. Similarly, the expression of several other iron-related genes is influenced
in the choroid plexus by the inflammatory stimulus. Using primary cultures of rat choroid plexus
epithelial cells,we showthat this response is triggerednotonlydirectlybyLPSbutalsobymolecules
whose expression increases in the blood in response to inflammation, such as IL-6. Intracellular
conveyors of these signaling molecules include signal transducer and activator of transcription 3,
which becomes phosphorylated, and SMAD family member 4, whose mRNA levels increase soon
after LPS administration. This novel role for the choroid plexus-CSF barrier in regulating iron
metabolismmaybeparticularly relevant to restrict ironavailability formicroorganismgrowth, and
in neurodegenerative diseases in which an inflammatory underlying component has been
reported. (Endocrinology 150: 2822–2828, 2009)
Iron is a required element for normal cellular homeostasis, par-ticipating in processes that range from cell proliferation to
oxygen transport and energy metabolism (1, 2). Although iron
deficiency leads to conditions such as anemia, iron in excess, by
promoting free radical formation and oxidative stress, is dele-
terious for the organism.Thus, iron homeostasis has to be tightly
regulated.One of itsmajor regulators is hepcidin, a liver-derived
peptide hormone that modulates iron release from the intestine
into theplasma (3–6), the rate-limitingprocess in ironhomeosta-
sis (7). In addition, hepcidin also regulates iron efflux fromhepa-
tocytes and macrophages into the bloodstream. Iron is taken up
from the diet by enterocytes and is released into the bloodstream
through the iron exporter ferroportin. In conditions of iron suf-
ficiency, hepcidin mediates ferroportin internalization and deg-
radation by the enterocyte (8). As a consequence, iron is kept
within the enterocyte, which results in lower iron release into the
circulation. It has been shown that increased hepcidin levels are
associated with anemia (7, 9), whereas decreased levels are as-
sociated with iron-overload diseases (7). Once in the blood, iron
is mostly bound to plasma proteins, particularly to transferrin,
and is delivered to cells mainly through transferrin receptor
1-mediated endocytosis (10, 11).Within cells, iron can be stored
bound to ferritin (12).
Although the mechanisms regulating iron homeostasis are
relatively well described in the periphery, less information is
available on brain iron metabolism. It has been proposed that
iron uptake by the brain depends on transferrin-mediated endo-
cytosis by endothelial cells of the blood-brain barrier (10, 13).
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Iron would then be likely released through ferroportin (14) into
the interstitial fluid of the brain parenchyma to be taken up by
neurons and glia cells. Iron transfer into the brain also occurs at
the choroid plexus (15), and into the cerebrospinal fluid (CSF),
because transferrin (16), transferrin receptor type 1 (17), and
ferroportin (18) are present in the choroid plexus epithelial cells.
Iron homeostasis is challenged in several conditions. Among
these are infectious diseases. Because microorganisms need iron
for survival and proliferation, the host promptly responds by
decreasing iron availability. This is accomplished by changes in
the levels of several iron-related proteins, such as ferritin and
ceruloplasmin (19). However, most microorganisms secrete sid-
erophores,moleculeswith higher affinity for iron than themajor
plasma iron-carrier proteins (20). In response, the host secretes
lipocalin 2 (21, 22), a protein that has the ability to sequester
iron-loaded siderophores (23). Of relevance, it has been recently
shown that lipocalin 2 is quickly synthesized and secreted by the
choroid plexus into the CSF upon an inflammatory stimulus
induced in the periphery (24). This observation suggested that
limiting ironavailability tomicroorganisms is part of the strategy
set by the choroid plexus to fight potential infections of the cen-
tral nervous system. Taken together, these observations
prompted us to further investigate iron metabolism in the cho-
roid plexus in response to inflammation.Thedata presentedhere
highlight a novel function for the choroid plexus in iron ho-
meostasis. We suggest that the choroid plexus has, for the brain,
a role similar to that played by both the liver and the intestine in
iron homeostasis in the periphery.
Materials and Methods
Animals and lipopolysaccharide (LPS) injection
In vivo experiments were conducted using 8- to 9-wk-old C57BL/6
mice and 8- to 9-wk-old Wistar rats (Charles River, Barcelona, Spain),
in accordance with the European Community Council Directive 86/09/
EEC guidelines for the care and handling of laboratory animals. Animals
weremaintained under 12-h light, 12-h dark cycles at 22–24C and 55%
humidity, and fed with regular rodent’s chow and tap water ad libitum.
To reduce the stress-induced changes in the hypothalamus-pituitary axis
associated with the injection, animals were handled for 1 wk before the
beginning of the experiments. Animals were given LPS (Escherichia coli,
serotype O26:B6; Sigma-Aldrich Corp., St. Louis, MO) (5 g/g body
weight) ip; control animals were injected with vehicle (0.9%NaCl). For
primary culture studies, rat choroid plexus epithelial cells were obtained
from neonate (postnatal d 3 or 4)Wistar rats born from control females.
One, 3, 6, 12, 24, or 72 h after LPS injection, mice were anesthetized
with ketamine hydrochloride (150 mg/kg) plus medetomidine (0.3 mg/
kg), transcardially perfused with cold saline and killed. For the mRNA
studies, choroid plexuseswere rapidly removed under conventional light
microscopy (SZX7; Olympus, Hamburg, Germany), frozen in dry ice,
and stored at 80 C. At least five pools (from three animals each) of
choroid plexus were prepared for each time point.
Ratswere similarly anesthetized 3, 6, 12, and24hafter LPS injection.
CSFwas collected from the cisternamagna, and choroid plexus removed
and frozen as described previously. An aliquot of each CSF sample was
used to verify the absence of blood contamination and the remainder
immediately frozen until use. Blood was collected, centrifuged, and se-
rumwas kept at80 C until use. The serumwas used for two proposes:
stimulation of primary cultures of rat choroid plexus epithelial cells (se-
rum obtained 3 and 6 h after LPS injection); and determination of he-
matological iron parameters (serum obtained 6, 12, and 24 h after LPS
treatment).
Primary cultures of rat choroid plexus epithelial cells
Epithelial cells from rat choroid plexus were prepared as described
previously by Strazielle andGhersi-Egea (25), withminormodifications.
Briefly, choroid plexuses from neonates were dissected under conven-
tional lightmicroscopy (SZX7). The tissuewas rinsed twice in PBS (with-
out Ca2 and Mg2), followed by a 25-min digestion with 0.1 mg/ml
pronase (Sigma-Aldrich) at 37 C. Predigested tissue was recovered by
sedimentation and briefly shaken in 0.025% trypsin (Invitrogen Corp.,
Carlsbad, CA) containing 12.5 g/ml deoxyribonuclease I (Roche Di-
agnostics, Basel, Switzerland). The supernatantwas thenwithdrawn and
kept on ice with 10% fetal bovine serum (Invitrogen). This step was
repeated five times. Cells were pelleted by centrifugation and resus-
pended in culture media consisting of Ham’s F-12 and DMEM (1:1)
(Invitrogen) supplemented with 10% fetal bovine serum, 2 mM glu-
tamine (Invitrogen), 50 g/ml gentamycin (Sigma-Aldrich), 5 g/ml in-
sulin, 5 g/ml transferrin, 5 ng/ml insulin-transferrin sodium selenite
(ITS, Sigma-Aldrich), 10 ng/ml epidermal growth factor (Sigma-Al-
drich), 2 g/ml hydrocortisone (Sigma-Aldrich), and 5 ng/ml basic fi-
broblast growth factor (Invitrogen). For further epithelial cells enrich-
ment, cells were incubated on plastic dishes for 2 h at 37 C. Because
epithelial cells do not attach to the plastic dish, the supernatant contain-
ing mostly these cells was collected and placed for seeding on laminin
(Boehringer-Ingelheim GmbH, Ingelheim, Germany) coated transwells
(Corning, Lowell, MA). Experiments were performed after the forma-
tion of confluent cell monolayers, approximately after 7 d in culture.
Once established, the upper chamber represents the fluid in contact with
the apical side of epithelial cells (the CSF side), whereas the lower cham-
ber represents the basolateral side (the blood side). Choroid plexus ep-
ithelial cellswere stimulated in the basolateral side, for 3 or 6 h,with IL-6
(2.8 ng/ml), LPS (1 g/ml), or serum obtained from rats previously in-
jected with LPS or with saline.
Gene expression measurements
Total RNA was isolated from choroid plexus using TRIZOL reagent
(Invitrogen). Fivehundrednanogramsof totalRNAwereamplifiedusing
the Superscript RNA amplification system (Invitrogen) according to the
manufacturer’s instructions. For the primary cultures of choroid plexus
epithelial cells, total RNA was collected and extracted using a Micro
Scale RNA Isolation Kit (Ambion, Inc., Austin, TX). RNA was reverse
transcribed using the Superscript First-Strand Synthesis System for RT-
PCR (Invitrogen). Quantitative real-time PCR (qRT-PCR) analysis was
used to measure the mRNA transcripts of the following genes (gene
abbreviations and gene names are specified in accordance with the hu-
man genome organization (HUGO) Gene Nomenclature Committee
available at http://www. genenames.org): ceruloplasmin (Cp), ferritin
heavy chain 1 (Fth1), ferritin light chain 1 (Ftl1), ferroportin (Slc40a1),
hepcidin (Hamp), hemochromatosis (Hfe), hemochromatosis type 2 (ju-
venile) (Hfe2, alias forHjv), IL-6 (Il6), SMADfamilymember4 (Smad4),
signal transducer and activator of transcription 3 (Stat3), toll-like re-
ceptor 4 (Tlr4), transferrin receptor type 1 (Tfrc, alias for Tfr1), and
transferrin receptor type 2 (Tfr2). The reference gene, hypoxanthine
guanine phosphoribosyl transferase (Hprt), was used as an internal stan-
dard for normalization because we have previously shown that its ex-
pression is not influenced by the experimental conditions (24). The
oligonucleotide primers for the transcripts analyzed were designed
using the Primer3 software (Whitehead Institute for Biomedical Re-
search, Cambridge, MA; http://fokker.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi; Ref. 43) on the basis of the GenBank sequences:
NM_001042611, NM_010239, NM_010240, NM_016917, NM_
032541, NM_031168.1, NM_ 010424, NM_027126, NM_008540,
NM_011486, NM_021297, NM_011638, NM_015799, and NM_
013556. The qRT-PCRs, using equal amounts of total RNA from each
sample, were performed on a LightCycler instrument (Roche Diagnos-
tics) using the QuantiTect SYBR Green RT-PCR reagent kit (QIAGEN,
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Hamburg,Germany). Product fluorescencewasdetected at the endof the
elongation cycle. All melting curves exhibited a single sharp peak at a
temperature characteristic of the primers used.
Analysis of (Tyr705)-STAT3 protein expression
For protein extraction,mouse choroid plexuseswere homogenized in
suspension buffer [NaCl 0.1M; Tris (pH8), 0.01M; EDTA (pH8), 0.001
M; andone tablet of complete protease inhibitor cocktail for 50mlbuffer;
Roche Diagnostics], followed by sonication for 30 sec in 2 Laemmli
buffer [sodium dodecyl sulfate 4%; Tris (pH 8), 0.12 M; glycerol 20%;
and dithiothreitol 0.2 M]. Proteins were quantified using the Bio-Rad
protein assay (Bio-Rad Laboratories, Inc., Hercules, CA). Samples were
separated by SDS-PAGE (50 g/lane) and transferred into a nitrocellu-
lose membrane. Membranes were then stained with Ponceau S (Sigma-
Aldrich) to confirm transfer efficiency; blocked with 5% skim milk in
PBS, and probed with antiphospho (Tyr705)-STAT3 antibody (diluted
to 1:1000; Cell Signaling Technology, Inc., Danvers, MA) at 4 C over-
night.Membraneswerewashed and incubatedwith goat antirabbit IgG-
horseradish peroxidase (Santa Cruz Biotechnology, Inc., Santa Cruz,
CA), diluted to 1:10,000. Each blotwas developed using the SuperSignal
West Pico Chemiluminescent Substrate (Pierce, Rockford, IL) and ex-
posed to x-ray film. Finally, the membranes were stripped with a 2%
sodiumdodecyl sulfate, 100mM-mercaptoethanol solutionwarmed to
50 C for 30 min, thoroughly washed, blocked and reblotted with mouse
anti--tubulin (Santa Cruz Biotechnology), and diluted to 1:5000 to
normalize for protein load.
Hepcidin prohormone measurements
The quantification of the hepcidin prohormone in the CSF was done
using the DRG hepcidin prohormone ELISA kit (DRG Instruments
GmbH, Marburg, Germany). This kit is optimized for measuring pro-
hepcidin in serum and urine, for which there is a reported intraassay
variation less than 5% and an interassay variation less than 10%. Be-
cause no reports were available on the CSF levels, we first checked in a
set of CSF samples collected from rats 3, 6, and 12 h after LPS, and
concluded that pro-hepcidin could be measured using a total volume of
50 l. This volume was used in the present study, and the assay proce-
dures were performed following the manufacturer’s instructions.
Serum iron concentration and unsaturated iron-binding
capacity (UIBC)
Serum rat iron concentration and serumUIBCwere determinedusing
acommercial kit (BIOLABO,Maizy,France).UIBCwasused tocalculate
total iron binding capacity (TIBC) as follows: TIBC  serum iron 
UIBC. Because most of circulating iron is bound to transferrin, it is well
accepted to consider the transferrin saturationas the ratiobetween serum
iron concentration and TIBC.
Statistical analysis
Values are reported as mean SE. Statistical significance was deter-
mined using the nonparametric Mann-Whitney U test, with differences
considered significant at P  0.05.
Results
Peripheral administration of LPS alters the expression of
genes involved in iron metabolism in the mouse choroid
plexus
Hamp expression, which was rarely detectable, by qRT-PCR
in basal conditions, became consistently detectable after LPS
injection, from 1–12 h, reaching the maximum expression at 3 h
(Fig. 1A), and returning almost to basal levels at 24 h. Similar
induction was observed in rat choroid plexus (data not shown).
In accordance with the up-regulation of the Hamp gene in the
choroid plexus, the ability to detect hepcidin prohormone in the
CSF increased upon LPS injection. Although in basal conditions
we could only detect pro-hepcidin in one of five rat CSF samples,
this number increased to two of six at 3 h, three of six at 6 h, and
returned to one of five at 12 h.
We next looked for the expression of genes encoding for tran-
scription factors described in the liver to modulate Hamp ex-
pression in response to inflammation, namely that of Stat3 and
Smad4. The expression of Stat3 (Fig. 1B) increased as soon as 3 h
after LPS administration, and that of Smad4 (Fig. 1C) at 6 h,
returning to basal levels at 72 h. The increased expression of
Stat3 corresponded to the expected activation of STAT3because
it became phosphorylated from 1 h until 6 h after LPS admin-
istration (Fig. 2).
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FIG. 1. The expression levels of mouse genes encoding for hepcidin and for
potential modulators of Hamp expression are increased in response to LPS. A,
Hamp expression was strongly induced by peripheral LPS administration, reaching
a maximum level at 3 h and returning to basal levels after 24 h. The genes
encoding for the upstream regulators of Hamp expression Stat3 (B), Smad4 (C),
Tfr2 (D), and Il6 (E) were also induced in the choroid plexus after LPS
administration, whereas those encoding for Hjv (F), Hfe (G), and Tlr4 (H) were
not altered. Results are expressed as the ratio between the gene of interest and
that of the reference gene Hprt. Data are represented as mean  SE; n  5 pools
(from three animals each) of the choroid plexus for each time point. *, P  0.05
vs. saline.
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SMAD4 and STAT3 participate in several signaling trans-
duction pathways. In the context of iron metabolism, and par-
ticularly to what has been described regardingHamp expression
in the periphery, three pathways are of particular relevance:
those mediated by LPS, IL-6, and the bone morphogenetic pro-
tein (BMP)/SMAD pathway. Although activation of these path-
ways does not necessarily require increased expression of recep-
tor proteins,we next investigated someof their components. The
expression of Tfr2 (Fig. 1D) increased from 6–24 h after LPS
administration, whereas no statistically significant differences
were observed for Hjv (Fig. 1F) and Hfe (Fig. 1G).
A key modulator of the liver acute-phase response is IL-6,
whose levels increase in the blood in response to inflammation.
Similarly, we observed a rapid and transient up-regulation of Il6
expression in the choroid plexus, which peaked at 3 h after LPS
injection and returned to basal levels at 12 h (Fig. 1E). Because
the response to LPS is mediated by the TLR4, which is present in
the choroid plexus in basal conditions, we measured the expres-
sion of Tlr4 and found that it was not altered by the inflamma-
tory stimulus (Fig. 1H).
Other iron-related genes are influenced by inflammation in
the liver (19). As an attempt to characterize better the overall
alterations in the choroid plexus iron metabolism, we next in-
vestigated the expression levels of genes encoding for key iron-
related proteins. Although no statistically significant differences
were observed for the expression ofTfr1 (Fig. 3A), Slc40a1 (Fig.
3B), and Ftl1 (Fig. 3C), the latter seems to present a trend toward
increase and Tfr1 toward decrease. The expression of Fth1 (Fig.
3D) and Cp (Fig. 3E) were significantly up-regulated by periph-
eral inflammation.
Triggering effectors of the choroid plexus response
The choroid plexus, located within the cerebral ventricles, is
composed of a vascularized stroma surrounded by a tight layer
of epithelial cells (26). Therefore, two aspects of the choroid
plexus response to peripheral inflammation should be consid-
ered: 1) inwhat extent the response ismediated specificallyby the
choroid plexus epithelial cells, which is particularly relevant be-
cause these cells contribute to the composition of theCSF; and 2)
because LPS administration in the periphery induces an acute-
phase response that results in an increase in the blood concen-
tration of several immune modulators and proteins (e.g. such as
IL-6), it is of relevance to identify which are the triggering effec-
tors of the choroid plexus response. To address these questions,
we used primary cultures of rat choroid plexus epithelial cells.
We chose the rat for two reasons: 1) the amount of tissue is
considerably greater when compared with the mouse, and 2)
as a second animal model for determining the choroid plexus
response.
When rat cells were stimulated in the basolateral side with
serum obtained from rats previously injected with LPS (serum
collected3 and6hafter LPS injection), an inductionof theHamp
gene was observed (Fig. 4A). To investigate further which mol-
eculeswithin the serumwere responsible for the observed effects,
cells were incubated with either LPS or IL-6 alone. As shown in
Fig. 4B, both LPS and IL-6were able to contribute directly to the
alteredHamp expression pattern. The concentration of IL-6was
chosen considering the levels of IL-6 present in the mouse serum
1 h after the administration of LPS (data not shown). The con-
centration of LPS usedwas based on its effects in inducingHamp
expression in human monocyte cell cultures (27). Similarly, se-
rum (Fig. 4C) andLPSor IL-6 alone (Fig. 4D)were able to induce
the expression of the gene encoding for ceruloplasmin.
These observations show that epithelial cells of the choroid
plexus respond to the inflammatory stimulus, and that at least
LPS and IL-6 are triggering modulators of such response.
Serum iron concentration and UIBC
To characterize whether the LPS stimulus was inducing the ap-
propriate response in iron metabolism in the periphery, we mea-
sured serum iron levels and serum transferrin saturation. As ex-
pected (28), LPS administration induced a decrease in total serum
iron levels, TIBC and transferrin saturation (data not shown). A
similar attempt was made with respect to the CSF, but up to a
volume of 100 l pools, the concentration was below detection.
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FIG. 2. Peripheral LPS injection induces a rapid and transient phosphorylation of
STAT3. Proteins extracted from mouse choroid plexus collected 1–24 h after LPS
administration were separated by SDS-PAGE (50 g/lane) and probed with
antiphospho (Tyr705)-STAT3. -Tubulin was used to normalize for protein load.
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Discussion
This study shows that the expression of iron-related genes in the
choroid plexus is influenced by inflammatory stimulus induced
in the periphery. This response seems to be quick and transient,
and highlights the choroid plexus as a site of regional iron ho-
meostasis. It includes not only hepcidin, the key hormone in iron
metabolism, but also iron-related proteins and signaling-trans-
duction molecules. Altogether, and because the choroid plexus
gene expression profilewill ultimately influence the composition
of theCSF, this responsemaybe transmitted to neuronal and glia
cells within the brain parenchyma.
We first observed that the gene encoding for hepcidin, rarely
detected in basal conditions, was strongly up-regulated in the
choroid plexus promptly after LPS administration. This corre-
lated with the increased secretion of pro-hepcidin into the CSF
and may indicate increased levels of hepcidin in the CSF (even
though to date, no clear relation between pro-hepcidin and hep-
cidin has been established) (29). Because the choroid plexus is
composed not only of epithelial cells but also of a stroma con-
taining endothelial cells of blood vessels and eventually immune
cells, we next asked if epithelial cells of the choroid plexus were
responsible for up-regulating the expression of genes encoding for
hepcidin and other iron-related genes. Stimulation of the basolat-
eral membrane of rat epithelial choroid plexus primary cells with
LPS (to mimic the environment to which the choroid plexus is ex-
posed in vivo) triggered the up-regulation ofHamp and of Cp ex-
pression. The direct effect of LPS is likely mediated by interaction
with the cognate receptor TLR4, present in the basolateral mem-
brane of choroid plexus epithelial cells (30)
andwhose expressionwe found unaltered by
LPS.
LPS is known to induce an acute-phase
response in the liver and in other organs,
and these react by secreting proteins into
the bloodstream (19), such as ILs that can
also activate the choroid plexus response.
Among these is IL-6, previously shown to
regulateHamp expression in the liver, upon
interaction with the cognate cellular re-
ceptor, and through the STAT3 signaling
transduction pathway (31–35). The same
mechanism seems to be operational in the
choroid plexus. In accordance, choroid
plexus epithelial cells respond to both LPS
and IL-6 applied to the basolateral side of
the cells by inducing the expression of
Hamp and Cp. Supporting the IL-6-medi-
ated signaling transduction pathway, in-
creased phosphorylation of STAT3was ob-
served in the choroid plexus collected from
mice upon administration of LPS. One in-
teresting aspect to refer is the observation
that when LPS or IL-6 were applied to the
culture media in contact with the apical
membrane of the choroid plexus epithelial
cells, no effect was observed in the expres-
sion of Hamp. Therefore, and at least with respect to LPS and
IL-6, the cognate receptors seem to be located in the basolateral
(facing the blood) membrane.
Other pathways involved in controlling the expression of
iron-related genes have been the focus of intense research (36).
Patients with mutations in Hfe, Tfr2, or Hjv show iron deposi-
tion that is similar and consistent with elevated iron absorption,
suggesting that these molecules may contribute to the regulation
ofHamp expression. In the present study, we did not find alter-
ations in the expression levels ofHfe orHjv. However, therewas
a strong increase in the expression ofTfr2 after LPS stimulation.
Interestingly, all these molecules belong to the BMP signaling
complex that is themost powerfulmechanismknown to activate
hepcidin transcription through activation of the transcription
factor SMAD4 (35). Of notice, we show here that the expression
of Smad4 is likewise induced by LPS. Further support for the
involvement of TFR2-mediated effect on Hamp regulation
comes from the observation that Tfr2-mutant mice have down-
regulated expression of Hamp (37). In addition, the TFR2 and
the IL-6-mediated pathways seem to cross talk sinceWang et al.
(38) reported that the liver-specific disruption of Smad4 results
in amarkedly decreasedHamp expressionwhen stimulatedwith
IL-6. Similarly, a recent study using human hepatocyte cell cul-
tures showed that mutations in the BMP-response element
strongly impairHamp activation in response to IL-6 (35). There-
fore, the effect of IL-6 in the choroid plexus may, as well, be
mediated by both SMAD4 and STAT3 signaling.
The expression of Il6 itself was also strongly up-regulated
soon after the LPS stimulus, which fits with the increased con-
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centration of IL-6 in the CSF. Because molecules within the CSF
may ultimately equilibrate with the interstitial fluid of the brain
parenchyma, this may be important in the regulation of Hamp
expression observed in brain regions such as the cortex in re-
sponse to inflammation (28).
Another relevant issue regards the direct action of hepcidin in
mediating ferroportin internalization and degradation, a well-
characterized mechanism to reduce iron release into the blood-
stream (5, 8). Of notice, the relation between ferroportin inter-
nalization and degradation and the levels of ferroportin gene
(Slc40a1) expression seems to be tissue specific: whereas syn-
thetic hepcidin has reduced Slc40a1 expression in spleen mac-
rophages, it produced no effect in duodenum (39), which seems
also to be the case in the choroid plexus because we observed no
altered Slc40a1 expression.
Regardless of the precise mechanisms involved, the overall
response of the choroid plexus to peripheral inflammation in-
cludes changes in the expression of genes implicated in iron me-
tabolism, thus suggesting a role for the choroid plexus in the
regulation of brain iron homeostasis. We propose that, upon
exposure to peripheral inflammatory stimuli, these modifica-
tions lead to a reduction in iron availability in the CSF (Fig. 5).
The increase in hepcidin levels induced by the inflammatory
stimulus may increase ferroportin internalization, which, as a
consequence, can decrease ferroportin-mediated iron release
into the CSF, due to the specific localization of ferroportin on
the apical membrane of the choroid plexus epithelial cell (18). The
up-regulation of FTH1 may promote storage of iron inside the
epithelial cells of the choroid plexus. In addition, increased se-
cretion of ceruloplasmin may facilitate iron binding to trans-
ferrin and internalization by cells of the brain parenchyma. Of
notice and as previously shown (24), lipocalin 2 is also synthe-
sized and secreted into the CSF in response to LPS. Collectively,
the present and earlier results (24) show that the choroid plexus
responds to inflammatory stimuli by restricting iron availability
in the CSF.
The presented ability of the choroid plexus to regulate iron
metabolism in conditionsof peripheral inflammationmightbeof
relevance for diseases such as Alzheimer’s andmultiple sclerosis.
Theobservations that an inflammatory componentmayunderlie
such diseases (40), that iron accumulates with age (41), and that
ceruloplasmin-deficient mice exhibit increased iron accumula-
tion and demyelination when exposed to LPS (42), warrant
that additional studies to clarify the regional role of the cho-
roid plexus in iron metabolism are necessary and of great
opportunity.
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